| 臺大學術典藏 |
2021-02-02T00:47:00Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Lin C.-C.;Hsu C.-H.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:00Z |
High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan
|
Huang P.-C.;Huang C.-Y.;Huang S.-W.;Lai M.-K.;Yu H.-J.;Chen J.;Yeong-Shiau Pu; Huang P.-C.; Huang C.-Y.; Huang S.-W.; Lai M.-K.; Yu H.-J.; Chen J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:01Z |
Primary amyloidosis of the urinary bladder
|
Huang C.-Y.;Shun C.-T.;Huang K.-H.;Chen J.;Yeong-Shiau Pu; Huang C.-Y.; Shun C.-T.; Huang K.-H.; Chen J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:01Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour T.-C.;Yeong-Shiau Pu;Lin C.-C.;Huang S.-W.;Chen J.;Chiu A.W.;Chen C.-J.;Huang C.-Y.; Hour T.-C.; YEONG-SHIAU PU; Lin C.-C.; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:01Z |
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells
|
Yeong-Shiau Pu;Hsieh M.-W.;Wang C.-W.;Liu G.-Y.;Huang C.-Y.;Lin C.-C.;Guan J.-Y.;Lin S.-R.;Hour T.-C.; YEONG-SHIAU PU; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; Huang C.-Y.; Lin C.-C.; Guan J.-Y.; Lin S.-R.; Hour T.-C. |
| 臺大學術典藏 |
2021-02-02T00:47:02Z |
Diet, vegetarian food and prostate carcinoma among men in Taiwan
|
Chen Y.C.;Chiang C.I.;Lin R.S.;Yeong-Shiau Pu;Lai M.K.;Sung F.-C.; Chen Y.C.; Chiang C.I.; Lin R.S.; YEONG-SHIAU PU; Lai M.K.; Sung F.-C. |
| 臺大學術典藏 |
2021-02-02T00:47:02Z |
An improved HPLC method for determination of carotenoids in human serum
|
Rajendran V.;Yeong-Shiau Pu;Chen B.H.; Rajendran V.; YEONG-SHIAU PU; Chen B.H. |
| 臺大學術典藏 |
2021-02-02T00:47:02Z |
Resistance to paclitaxel is proportional to cellular total antioxidant capacity
|
Ramanathan B.;Jan K.-Y.;Chen C.-H.;Hour T.-C.;Yu H.-J.;Yeong-Shiau Pu; Ramanathan B.; Jan K.-Y.; Chen C.-H.; Hour T.-C.; Yu H.-J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:02Z |
The 18th International Symposium: Controversies in Prostate Cancer Diagnosis and Treatment
|
Yeong-Shiau Pu;Fujimoto H.;Kakizoe T.;Myers R.; YEONG-SHIAU PU; Fujimoto H.; Kakizoe T.; Myers R. |
| 臺大學術典藏 |
2021-02-02T00:47:03Z |
Negative modulation of androgen receptor transcriptional activity by Daxx
|
Lin D.-Y.;Fang H.-I.;Ma A.-H.;Huang Y.-S.;Yeong-Shiau Pu;Jenster G.;Kung H.-J.;Shih H.-M.; Lin D.-Y.; Fang H.-I.; Ma A.-H.; Huang Y.-S.; YEONG-SHIAU PU; Jenster G.; Kung H.-J.; Shih H.-M. |
| 臺大學術典藏 |
2021-02-02T00:47:03Z |
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
|
Hour T.-C.;Huang C.-Y.;Lin C.-C.;Chen J.;Guan J.-Y.;Lee J.-M.;Yeong-Shiau Pu; Hour T.-C.; Huang C.-Y.; Lin C.-C.; Chen J.; Guan J.-Y.; Lee J.-M.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:04Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei D.-J.;Hsu H.-C.;Lee P.-H.;Jeng Y.-M.;Yeong-Shiau Pu;Chen C.-N.;Lee Y.-C.;Chou W.-C.;Chang C.-J.;Ni Y.-H.;Chang M.-H.; Tsuei D.-J.; Hsu H.-C.; Lee P.-H.; Jeng Y.-M.; YEONG-SHIAU PU; Chen C.-N.; Lee Y.-C.; Chou W.-C.; Chang C.-J.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2021-02-02T00:47:04Z |
Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470
|
Yeong-Shiau Pu;Do K.-A.;Luo W.;Logothetis C.J.;Lin S.-H.; YEONG-SHIAU PU; Do K.-A.; Luo W.; Logothetis C.J.; Lin S.-H. |
| 臺大學術典藏 |
2021-02-02T00:47:04Z |
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells
|
Yeong-Shiau Pu;Hour T.-C.;Chuang S.-E.;Cheng A.-L.;Lai M.-K.;Kuo M.-L.; YEONG-SHIAU PU; Hour T.-C.; Chuang S.-E.; Cheng A.-L.; Lai M.-K.; Kuo M.-L. |
| 臺大學術典藏 |
2021-02-02T00:47:04Z |
Changing trends of prostate cancer in Asia
|
Yeong-Shiau Pu;Chiang H.-S.;Lin C.-C.;Huang C.-Y.;Huang K.-H.;Chen J.; YEONG-SHIAU PU; Chiang H.-S.; Lin C.-C.; Huang C.-Y.; Huang K.-H.; Chen J. |
| 臺大學術典藏 |
2021-02-02T00:47:05Z |
Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation
|
Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.;Yeong-Shiau Pu; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:05Z |
Cytotoxicity of arsenic trioxide to transitional carcinoma cells
|
Yeong-Shiau Pu;Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.; YEONG-SHIAU PU; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H. |
| 臺大學術典藏 |
2021-02-02T00:47:05Z |
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway
|
Yeong-Shiau Pu;Hour T.-C.;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.; YEONG-SHIAU PU; Hour T.-C.; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Yeong-Shiau Pu;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; YEONG-SHIAU PU; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China
|
Yin L.;Yeong-Shiau Pu;Liu T.-Y.;Tung Y.-H.;Chen K.-W.;Lin P.; Yin L.; YEONG-SHIAU PU; Liu T.-Y.; Tung Y.-H.; Chen K.-W.; Lin P. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer
|
Lin C.-C.;Hsu C.-H.;Chen J.;Tsai T.-C.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Chen J.; Tsai T.-C.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma
|
Hsu C.-H.;Chen J.;Wu C.-Y.;Cheng A.-L.;Yeong-Shiau Pu; Hsu C.-H.; Chen J.; Wu C.-Y.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:07Z |
Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients
|
Liao C.-H.;Liu S.-P.;Yeong-Shiau Pu;Huang C.-Y.;Yu H.-J.;Chen J.; Liao C.-H.; Liu S.-P.; YEONG-SHIAU PU; Huang C.-Y.; Yu H.-J.; Chen J. |
| 臺大學術典藏 |
2021-02-02T00:47:07Z |
Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells
|
Yeong-Shiau Pu;Chen J.;Huang C.-Y.;Guan J.-Y.;Lu S.-H.;Hour T.-C.; YEONG-SHIAU PU; Chen J.; Huang C.-Y.; Guan J.-Y.; Lu S.-H.; Hour T.-C. |
| 臺大學術典藏 |
2021-02-02T00:47:07Z |
Blood and urine cadmium levels in relation to demographic and life style in middle aged and elderly men
|
Chen Y.C.;Yeong-Shiau Pu;Lin R.S.;Yang C.Y.;Lai M.K.;Liu S.H.;Sung F.-C.; Chen Y.C.; YEONG-SHIAU PU; Lin R.S.; Yang C.Y.; Lai M.K.; Liu S.H.; Sung F.-C. |
